Jonathan S. Harrison

Author

Rutgers, The State University of New Jersey ORCID

Also Known As

Harrison, J. W., Harrison,John W., J Harrison, J S Harrison, J. Harrison, J. S. Harrison, J.S. Harrison, JONATHAN HARRISON, Jonathan Cooper, Jonathan Harrison

112

Publications

2.9K

Citations

H-Index

103

Concepts

All Affiliations

Rutgers, The State University of New Jersey Rutgers New Jersey Medical School Ben-Gurion University of the Negev Johnson University University Hospital, Newark

About

Jonathan S. Harrison is an author at Rutgers, The State University of New Jersey specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	34	1.1K
2	Health Sciences	4	4	110
3	Biomedical Engineering	3	3	281
4	Engineering	2	2	203
5	Public Health	1	1	17

Jonathan S. Harrison

Publications

Citations

H-Index

Page 1

	Year	Citations
Veto-Like Activity of Mesenchymal Stem Cells: Functional Discrimination Between Cellular Responses to Alloantigens and Recall Antigens Julius A. Potian, Hana Aviv, Nicholas M. Ponzio, The Journal of Immunology	2003	435
Demonstration of the Safety and Feasibility of Robotically Assisted Percutaneous Coronary Intervention in Complex Coronary Lesions Ehtisham Mahmud, Jesse Naghi, Lawrence Ang, JACC: Cardiovascular Interventions Percutaneous Coronary InterventionComplex Coronary LesionsEngineeringCardiovascular DiseaseMedicine	2017	151
Sintered hydroxyfluorapatites—IV: the effect of fluoride substitutions upon colonisation of hydroxyapatites by mouse embryonic stem cells Jonathan S. Harrison, Amanda J. Melville, John S. Forsythe, Biomaterials Regenerative MedicineDevelopmental BiologyHydroxyapatiteFluoride SubstitutionsStem Cell Research	2004	78
Hematopoietic growth factor inducible neurokinin-1 type: a transmembrane protein that is similar to neurokinin 1 interacts with substance P Persis Bandari, Jing Qian, Ghassan Yehia, Regulatory Peptides Protein FunctionSignal TransductionImmunologyNeuropeptide ReceptorCytoskeleton	2003	59
Cytoreductive surgery and intraoperative hyperthermic chemoperfusion for advanced ovarian carcinoma Trevor Reichman, Bernadette Cracchiolo, Jahir Sama, Journal of Surgical Oncology	2005	57
The rationale for deltanoids in therapy for myeloid leukemia: Role of KSR–MAPK–C/EBP pathway George P. Studzinski, Xuening Wang, Yan Ji, The Journal of Steroid Biochemistry and Molecular Biology Hematological MalignancySignal TransductionImmunologyHematologyMyeloid Leukemia	2005	53
High-dose doxorubicin, etoposide, and cyclophosphamide with stem cell reinfusion in patients with metastatic or high-risk primary breast cancer George Somlo, James H. Doroshow, Stephen J. Forman, Cancer	1994	52
Severe von Willebrand disease due to a defect at the level of von Willebrand factor mRNA expression: detection by exonic PCR-restriction fragment length polymorphism analysis. William C. Nichols, Susan E. Lyons, Jonathan S. Harrison, Proceedings of the National Academy of Sciences ThrombosisAllelic VariantFamily MembersVwf AlleleMedicine	1991	52
Colonization and maintenance of murine embryonic stem cells on poly(α-hydroxy esters) Jonathan S. Harrison, S. Pattanawong, John S. Forsythe, Biomaterials Regenerative MedicineEmbryo CultureTissue EngineeringDevelopmental Biologyα-Hydroxy Esters	2004	52
Inhibition of Cot1/Tlp2 oncogene in AML cells reduces ERK5 activation and upregulates p27<sup>Kip1</sup>concomitant with enhancement of differentiation and cell cycle arrest induced by silibinin and 1,25-dihydroxyvitamin D<sub>3</sub> Xuening Wang, Elżbieta Gocek, Victoria Novik, Cell Cycle	2010	47

Page 1